YD23 is a PROTAC molecule designed to target and degrade SMARCA2, exploiting the synthetic lethality with SMARCA4. It modulates chromatin accessibility, particularly at gene enhancers involved in cell cycle and growth regulation, with selective effects in SMARCA4-deficient cells.
Usually ships within 24 hours.